Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Withdrawn 2 Unknown 2 Recruiting 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 22 Breast Neoplasms 14 Neoplasms 9 Fatigue 5 Prostatic Neoplasms 4 Obesity 4 Pancreatic Neoplasms 3 Colorectal Neoplasms 3 Peripheral Nervous System Diseases 2 Overweight 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lung Neoplasms 2 Cognitive Dysfunction 2 Cardiovascular Diseases 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Smoking 1 Skin Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Osteolysis 1 Non-alcoholic Fatty Liver Disease 1 Neuroectodermal Tumors, Primitive 1 Neurocognitive Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Metabolic Syndrome 1

Interventions

Oxaliplatin 14 Cetuximab 11 Leucovorin 9 Fluorouracil 9 Magnetic Resonance Spectroscopy 8 Nivolumab 7 pembrolizumab 6 Capecitabine 6 encorafenib 5 Irinotecan 5 Bevacizumab 5 dehydroftorafur 4 Specimen Handling 4 adagrasib 3 Immunoglobulin G 3 Disulfides 3 Biopsy 3 selpercatinib 2 durvalumab 2 cemiplimab 2 X-Rays 2 Watchful Waiting 2 Standard of Care 2 Radiotherapy 2 Panitumumab 2 Observation 2 Ipilimumab 2 Injections 2 Gemcitabine 2 Folfox protocol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Colonic Neoplasms × Exercise × Clear all

NCT05579340 2026-02-24

POET-mCRC

Rigshospitalet, Denmark

Phase NA Active not recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡